The clinically diagnosed DLB cases included in our study might therefore have a purer, less PD-like genetic profile than studies based on brain bank cases, a possible explanation for why we do not find the previously PD-associated risk loci like MAPT in our analysis. The gene discussed is MAPT; the disease is Lewy body dementia.